Potential for receptor-based antiviral drugs against SARS

Lancet. 2003 Jul 5;362(9377):77. doi: 10.1016/S0140-6736(03)13818-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • CD13 Antigens / antagonists & inhibitors*
  • Humans
  • Severe Acute Respiratory Syndrome / drug therapy*

Substances

  • Antiviral Agents
  • CD13 Antigens